biological makers

Clinical, biological, and prognostic impact of supplemental oxygen in fibrotic interstitial lung disease

Interstitial lung disease (ILD) is a progressive lung disorder with no effective treatment. Oxygen is often used to relieve symptoms at the end of life, but the evidence supporting oxygen use in these patients is based on limited data from other diseases. The lack of data on the benefits of oxygen in patients with ILD has resulted in uncertain criteria for its use and limited access to this potentially important medication.

Primary Investigator: 
Year: 
2019
Subscribe to RSS - biological makers